10,000 results
·
79ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·April 3, 2026
SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC
FDA Adverse Event
Injury
·COOK INC·Product code LJS·December 22, 2021
SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC
FDA Adverse Event
Injury
·COOK INC·Product code LJS·July 1, 2017
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·April 2, 2026
Catheter, intravascular, therapeutic, short-term less than 30 days
FDA Adverse Event
Malfunction
·COOK INC·Product code FOZ·November 10, 2022
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·April 7, 2026
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·March 2, 2026
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026
BD PRECISIONGLIDE¿ NEEDLE
FDA Adverse Event
Malfunction
·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·December 14, 2017
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026
ABBOCATH-T 20G 1-1/4
FDA Adverse Event
Malfunction
·AMSINO MEDICAL CO., LTD·Product code FOZ·April 27, 2009
INSYTE AUTOGUARD PNK 20GA X 1.16IN
FDA Adverse Event
Malfunction
·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·November 14, 2019
ARGYLE
FDA Adverse Event
Malfunction
·CARDINAL HEALTH, INC·Product code LJS·October 21, 2025
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
FDA Adverse Event
Malfunction
·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 25, 2019
BD NEXIVA¿ SINGLE PORT WITH MAXZERO¿ CLOSED IV CATHETER
FDA Adverse Event
Malfunction
·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FPA·March 8, 2023
ARROW, ARROWG+ARD AND ARROWG+ARD BLUE PLUS PRESSURE INJECTABLE CENTRAL VENOUS CATHETER. Product Usage: Indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring cental venous access including, but not limited to: multiple infusions of fluids, medications, or chemotherapy, infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values, frequent blood sampling or blood/blood component infusions, infusion of incompatible medications, central venous pressure monitoring, lack of usable peripheral IV sites, replacement of multiple peripheral sites for IV access and injection of contrast media.
FDA Enforcement
Class II
·Terminated·Arrow International Inc·July 13, 2016
BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER
FDA Adverse Event
Malfunction
·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 6, 2022
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
FDA Adverse Event
Malfunction
·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 26, 2019
VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT
FDA Adverse Event
Malfunction
·ETHICON INC.·Product code GAM·April 21, 2020